PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

35,669 stories, page 95 of 595

Advanced search
🌍Researchdoi.org

Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience

CrossrefOriginal source
🌍Researchdoi.org

A Scandinavian Perspective of the Projected Lifetime Cost-Effectiveness of Rivaroxaban Plus Aspirin in the COMPASS Trial

CrossrefOriginal source
🌍Researchdoi.org

Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy

CrossrefOriginal source
🌍Researchdoi.org

Development of HPTLC method for simultaneous estimation of Gatifloxacin and Flurbiprofen Sodium using 3 <sup>2</sup> factorial design

CrossrefOriginal source
🌍Researchdoi.org

Age associations, sex differences, and interrelationships of five skeletal maturity indicators: a cross-sectional study in a Korean clinical sample

CrossrefOriginal source
🌍Researchdoi.org

Gastrointestinal tolerance and compliance during a 2-week intervention of reformulated tube feeds with a plant-dominant protein blend in community-based adult patients on long-term nutritional support

CrossrefOriginal source
🌍Researchdoi.org

Investigating the Short-Term Reliability of Health-Related Physical Fitness Assessment via telehealth with in-person assessment among Young Adults: An Observational Study

CrossrefOriginal source
🌍Researchdoi.org

Burden of complex multimorbidity and disparities in care and support among older adults with palliative care needs in India- evidence from a nationally representative sample survey

CrossrefOriginal source
🌍Researchdoi.org

Artificial Intelligence in Echocardiography and Point-of-Care Ultrasound: Applications, Clinical Integration, and Future Directions

CrossrefOriginal source
🌍Researchdoi.org

Development of a recombinant Bacillus ligniniphilus L1 laccase-rice straw biochar composite for efficient deltamethrin bioremediation

CrossrefOriginal source
🌍Researchdoi.org

Exploiting Binary Eutectic Fatty Acid Systems for Thermoresponsive Nanocarriers: A Doxorubicin Delivery Approach

CrossrefOriginal source
🌍Researchdoi.org

Comparative Efficacy of Betamethasone-Ciprofloxacin- and Saline-Impregnated Nasal Packing Following Functional Endoscopic Sinus Surgery: A Randomized Controlled Trial

CrossrefOriginal source
🌍Researchdoi.org

Bulge Progenitor Cells: A Promising Frontier in Hair Follicle Regeneration and Clinical Translation

CrossrefOriginal source
🌍Researchdoi.org

Antibody-Drug Conjugates in the Treatment of Esophageal Cancer

CrossrefOriginal source
🌍Researchdoi.org

Effects of supervised exercise immediately after bariatric surgery: results from the EFIBAR randomized trial

CrossrefOriginal source
🌍Researchdoi.org

Cross-tier implementation gaps in pharmaceutical waste management: evidence from a system-level audit in Southern Thailand

CrossrefOriginal source
🌍Researchdoi.org

Institutional phronesis: theorizing how US primary care clinicians navigate competing incommensurate logics of efficiency, care, and market in clinical practice

CrossrefOriginal source
🌍Researchdoi.org

Systemic evaluation of immune cells and cytokines in patients with different clinical severity of Omicron infection

CrossrefOriginal source
🌍Researchdoi.org

Concurrent emergency head and cervical spine CT utilization: temporal trends, diagnostic yield, and clinical implications

CrossrefOriginal source
🌍Researchdoi.org

Moraxella species isolated from blood cultures in Europe (MORAXEu): a multicentre study of epidemiology and antimicrobial susceptibility with complementary phylogenomic analysis of publicly available genomes

CrossrefOriginal source
🌍Researchdoi.org

Ibero-American consensus on reactive arthritis: definition, diagnosis, and management

CrossrefOriginal source
🌍Researchdoi.org

Chloroquine and hydroxychloroquine retinopathy in a cohort with rheumatic diseases in Mexico: prevalence, risk factors, and retinopathy patterns

CrossrefOriginal source
🌍Researchdoi.org

Clinical practice guidelines for duodenal cancer 2025

CrossrefOriginal source
🌍Researchdoi.org

The effect of a smartphone-based educational intervention on the supportive care needs of family caregivers of patients with colorectal cancer: a randomized controlled trial

CrossrefOriginal source
🌍Researchdoi.org

Comment on “Survival of esophageal squamous cell carcinoma achieving pathological complete response after neoadjuvant immunochemotherapy”

CrossrefOriginal source
🌍Researchdoi.org

Comparative analysis of post-neurosurgical intracranial infections: distinct clinical-laboratory profile of coagulase-negative staphylococci versus other bacterial pathogens

CrossrefOriginal source
🌍Researchdoi.org

Video‐Assisted Versus Conventional Surgical Informed Consent in Visceral Surgery—A Cluster Quasi‐Randomized Clinical Trial

CrossrefOriginal source
🌍Researchdoi.org

When 88% Meets 72%: Refining the Clinical Relevance of Cesarean Scar Disorder Criteria

CrossrefOriginal source
🌍discoverynews.google.com

Retatutride: How the hunger for a new weight loss drug is feeding an industry of fakes

BBCOriginal source
🌍discoverynews.google.com

Retatutride: How the hunger for a new weight loss drug is feeding an industry of fakes

BBCOriginal source
🌍discoverynews.google.com

Krystal Biotech president, R&D Suma Krishnan sells $8.98m in stock

Investing.comOriginal source
🌍discoverynews.google.com

Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen

The Manila TimesOriginal source
🌍discoverynews.google.com

Krystal Biotech (KRYS) R&D head sells 25,000 shares under trading plan

Stock TitanOriginal source
🌍discoverynews.google.com

Krystal Biotech (NASDAQ: KRYS) CEO sells 25,000 shares under trading plan

Stock TitanOriginal source
🌍discoverynews.google.com

Teva Pharmaceutical Industries Limited (TEVA) Discusses Positive Topline Results for Anti-IL-15 Antibody in Phase IIa Celiac Disease Study - Slideshow (NYSE:TEVA) 2026-09-04

Seeking AlphaOriginal source
🌍discoverynews.google.com

Why Microstructure Intelligence Matters in Pharma Canva

pharmtech.comOriginal source
🌍discoverynews.google.com

PharmTech Weekly Roundup—September 4, 2026

pharmtech.comOriginal source
🌍discoverynews.google.com

Budget for specialty pharmaceutical benefits set at €6.73 billion

The Brussels TimesOriginal source
🌍discoverynews.google.com

Price to earnings forward of Beijing Science Sun Pharmaceutical Co., Ltd. Class A – SZSE:300485

tradingview.comOriginal source
🌍discoverynews.google.com

ADRX IPO News - siRNA biotech ADARx Pharmaceuticals files for a $100 million IPO

renaissancecapital.comOriginal source
🌍discoverynews.google.com

Health Care Down on Retreat From Risky Biotech Area - Health Care Roundup

marketscreener.comOriginal source
🌍discoverynews.google.com

Pharmaceutical Temperature-Controlled Shipping Boxes Market Outlook to 2035

IndexBoxOriginal source
🌍discoverynews.google.com

Louisiana et al. v. Food and Drug Administration: A case working its way through federal courts poses a dangerous threat to abortion access nationwide.

National Women's Law CenterOriginal source
🌍discoverynews.google.com

Novartis’ experimental cardiovascular drug fails a pivotal study

STATOriginal source
🌍Industrymatinasbiopharma.com

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Matinas BioPharmaOriginal source
🌍discoverynews.google.com

FDA rallies HRT manufacturers amid US-wide estradiol patch shortage

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.com

Krystal Biotech (NASDAQ: KRYS) holder to sell 25,000 founders shares

Stock TitanOriginal source
🌍discoverynews.google.com

Krystal Biotech (KRYS) insider moves to sell 2017 shares in a multimillion-dollar deal

Stock TitanOriginal source
🌍discoverynews.google.com

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

NovartisOriginal source
🌍Regulatoryargentina.gob.ar

ANMAT emitió una Carta de Advertencia a UGAL FARMACÉUTICA S.A. por incumplimientos a las Buenas Prácticas de Fabricación

ANMAT NoticiasOriginal source
🌍discoverynews.google.com

FDA Clears IND for Acepodia's Dual-Payload ADC ACE723

BioPharm InternationalOriginal source
🌍discoverynews.google.com

How Virtus Lifesci Biotech Products Etf (BBP) Affects Rotational Strategy Timing

Stock Traders DailyOriginal source
🌍discoverynews.google.com

Price to sales forward of CH Biotech R&D Co., Ltd. – TWSE:6534

tradingview.comOriginal source
🌍discoverynews.google.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

The Motley FoolOriginal source
🌍discoverynews.google.com

Cipla Partners With Qilu Pharmaceutical to Commercialize a Keytruda Biosimilar in the US

BioPharm InternationalOriginal source
🌍discoverynews.google.com

Gan & Lee Pharmaceuticals

Fierce BiotechOriginal source
🌍discoverynews.google.com

FDA green light for Zanvastro in Alexander disease

The Pharma LetterOriginal source
🌍Regulatoryargentina.gob.ar

ANMAT presentó la experiencia argentina en vigilancia y control post comercialización de dispositivos médicos

ANMAT NoticiasOriginal source
🌍discoverynews.google.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

The Globe and MailOriginal source
🌍discoverynews.google.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

AOL.comOriginal source